TARIS Biomedical
About:
TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.
Website: http://www.tarisbiomedical.com
Twitter/X: tarisbio
Top Investors: RA Capital Management, Bristol-Myers Squibb, Polaris Partners, Millhouse, Third Rock Ventures
Description:
TARIS Biomedical develops new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's system is designed to continuously release drugs in the bladder over weeks to months and is deployed and retrieved using minimally-invasive, in-office procedures, enabling drug release to be tailored to match the needs of each disease.
$113M
$10M to $50M
Lexington, Massachusetts, United States
2008-01-01
info(AT)TARISbio.com
Paul Janssen
11-50
2017-12-21
Private
© 2025 bioDAO.ai